The ligands of tumor cells bind to checkpoint proteins such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1), and lymphocyte activation gene-3 (LAG-3). This evidence concerns the gene CTLA4 and neoplasm.